Abstracts Archive - Page 1932 of 2607 - ACR Meeting Abstracts

Abstract Number: 914 • 2015 ACR/ARHP Annual Meeting
When Fibromyalgia Criteria Misclassify
Frederick Wolfe¹ and Winfried Häuser², ¹National Data Bank, Wichita, KS, ²Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany
Background/Purpose : The 2010 American College of Rheumatology (ACR) preliminary criteria for the diagnosis of fibromyalgia (FM2010) and its extension for clinical research by patient self-report…
Abstract Number: 915 • 2015 ACR/ARHP Annual Meeting
Defining Pain for Fibromyalgia Criteria: Multi-Site or Widespread? an Analysis of Data from Four UK Population-Based Studies
Gary J. Macfarlane¹, Linda E. Dean¹, Robert Bennett², Leslie J. Crofford³, Abimbola Ayorinde¹, Elisa Fluess¹, Daniel J. Clauw⁴, Mary-Ann Fitzcharles⁵, Don Goldenberg⁶, Eduardo Paiva⁷, Roland Staud⁸ and Lesley Arnold⁹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²SN-Office of Research & Development, Oregon Health & Science Univ, Portland, OR, ³Medicine, Vanderbilt University, Nashville, TN, ⁴Anesthesiology, University of Michigan, Ann Arbor, MI, ⁵MGH, Montreal, QC, Canada, ⁶Newton-Wellesley Hospital, Newton, MA, ⁷Sociedade Brasileira de Reumatologia, São Paulo, Brazil, ⁸University of Florida, Gainesville, FL, ⁹University of Cincinnati, Cincinnati, OH
Background/Purpose: The 1990 criteria for fibromyalgia (FM) remain the only set approved by the American College of Rheumatology (ACR). They require that pain be both…
Abstract Number: 916 • 2015 ACR/ARHP Annual Meeting
Assessing Alternative Selection Criteria for Fibromyalgia Patients within a Multicenter Chronic Pain Claims Database
Mark Gostine¹, Fred Davis¹, Bradley Roberts², Rebecca Risko², Joseph Cappelleri³, Michael Asmus⁴, Andrew Clair⁵ and Alesia Sadosky⁶, ¹Michigan Pain Consultants, PC, Grand Rapids, MI, ²ProCare Systems, Inc., Grand Rapids, MI, ³Biostatistics, Pfizer, Inc., Groton, CT, ⁴North American Medical Affairs, Pfizer, Inc., Middleton, WI, ⁵Pfizer Inc., New York, NY, ⁶Pfizer Inc,, New York, NY
Background/Purpose: Diagnosing FM is difficult because there is no specific laboratory test to confirm the disorder. Billing practices dictate that physicians assign ICD-9-CM (Corresponding International…
Abstract Number: 917 • 2015 ACR/ARHP Annual Meeting
Chronic Widespread Pain in Adolescents Is Highly Associated to Stress and Anxiety
Stefan Bergman^1,2,3, Ann Bremander^1,3,4, Anna-Carin Bergman⁵ and Sofia Brorsson⁶, ¹FoU Spenshult, Halmstad, Sweden, ²Primary Health Care Unit, Department of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, ³Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Lund, Sweden, ⁴School of Business, Engineering and Science, Halmstad University, Halmstad, Sweden, ⁵Sannarpsgymnasiet, Halmstad, Sweden, ⁶Health and Welfare, Dalarna University, Falun, Sweden
Background/Purpose: Chronic widespread pain (CWP), one of the hallmarks of fibromyalgia, is not uncommon in adolescents and it has previously been shown that adolescents with…
Abstract Number: 918 • 2015 ACR/ARHP Annual Meeting
Assessment of the Temporal Variation of the Fibromyalgia Patient Profile Between 2005 and 2013: Do Guidelines Inform Clinical Care?
Angeliki Karellis^1,2, Emmanouil Rampakakis¹, Peter A. Ste-Marie³, Yoram Shir³, John S. Sampalis^1,4 and Mary-Ann Fitzcharles^3,5, ¹JSS Medical Research, St-Laurent, QC, Canada, ²Department of Surgery, McGill University, Montreal, QC, Canada, ³Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ⁴McGill University, Montreal, QC, Canada, ⁵Division of Rheumatology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: In the last decade, interest in fibromyalgia (FM) has increased with the publication of revised diagnostic criteria and clinical guidelines. The 2010 and revised…
Abstract Number: 919 • 2015 ACR/ARHP Annual Meeting
Automated Case Identification of Lupus from an Electronic Health Record Using Novel Informatics Approaches
Sara G. Murray¹, Chris Tonner², Ben J. Marafino³, Sarah Haserodt⁴, Gabriela Schmajuk⁵ and Jinoos Yazdany³, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²Rheumatology, University of California, San Francisco, San Francisco, CA, ³University of California, San Francisco, San Francisco, CA, ⁴Internal Medicine, California Pacific Medical Center, San Francisco, CA, ⁵San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA
Background/Purpose: Systemic lupus erythematosus (SLE) can be difficult to study given the relatively low prevalence of the disease. While we are now collecting a…
Abstract Number: 920 • 2015 ACR/ARHP Annual Meeting
Patient Preferences for the Development of a Mobile Health (mHealth) Application (App) for Systemic Lupus Erythematosus (SLE) Patients: A Qualitative Study
Alana B. Levine¹, Adena Batterman², VP Bykerk¹, Aislinn Crank³, Su Jin Kim⁴, Juliette Kleinman⁵, Laura Leuenberger¹, Laura Robbins⁶, Jillian A. Rose³, Jane E. Salmon^1,3, Nadine Spring¹, My-Lan Tran⁷ and Roberta Horton², ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Social Work Programs, Hospital for Special Surgery, New York, NY, ³Hospital for Special Surgery, New York, NY, ⁴School of Social Work, Columbia University, New York, NY, ⁵Patient Care & Quality, Hospital for Special Surgery, New York, NY, ⁶Education & Academic Affairs, Hospital for Special Surgery, New York, NY, ⁷Department of Social Work Programs, Hospital for Special Surgery, New York City, NY
Background/Purpose: SLE patients face many challenges due to lupus, including pain, fatigue, managing medications and appointments, and emotional impact. Patients employ various strategies to manage…
Abstract Number: 921 • 2015 ACR/ARHP Annual Meeting
Poverty Associated with Increase in Damage in SLE over Two-Year Period
Edward H. Yelin¹, Laura Trupin², Jinoos Yazdany² and Stephanie Rush³, ¹University of California, San Francisco, San Francisco, CA, ²Rheumatology, UCSF, SF, CA, ³UCSF, SF, CA
Background/Purpose: Prior research has shown that persons with SLE in poverty have fewer physician visits for SLE and receive lower technical quality of care.…
Abstract Number: 922 • 2015 ACR/ARHP Annual Meeting
Factors Associated with Performance on Quality Measures Pertaining to Assessment of Disease Activity in Juvenile Idiopathic Arthritis
Lara H. Huber^1,2, Murray H. Passo³, Kristen Morella¹, Natasha M. Ruth⁴ and Pediatric Rheumatology Care and Outcomes Improvement Network, ¹Pediatrics, Medical University of South Carolina, Charleston, SC, ²Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, ³Division of Rheumatology PTD, Medical University of South Carolina, Charleston, SC, ⁴Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC
Background/Purpose: Assessment of disease activity is a critical step in the management of patients with juvenile idiopathic arthritis (JIA). The American College of Rheumatology provisional…
Abstract Number: 923 • 2015 ACR/ARHP Annual Meeting
Perceptions of Infectious Risk of Immunosuppressive Medications Among Treating Physicians
Rebecca Sharim¹, Leny Mathew², Michael George³, Preethi Thomas⁴ and Misha Rosenbach⁵, ¹Rheumatology, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Children's Hospital of Philadelphia, Philadelphia, PA, ³Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, ⁴Department of Rheumatology, Hospital of the University of Pennsylvania, Philadelphia, PA, ⁵Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA
Background/Purpose: Physicians often encounter patients who are treated with immunosuppressive agents and must consider the risk of infection that the medications may pose. We explored…
Abstract Number: 924 • 2015 ACR/ARHP Annual Meeting
Patient and Provider Factors in Optimal Gout Management
Brian Coburn¹, Kayli Bendlin², Harlan Sayles¹ and Ted R. Mikuls¹, ¹Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, ²Pharmacy Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE
Background/Purpose: Gout is the most common inflammatory arthritis worldwide. Despite its prevalence and the availability of effective therapies, studies have consistently characterized gout quality of…
Abstract Number: 925 • 2015 ACR/ARHP Annual Meeting
Musculoskeletal Ultrasound (MSK-US): Innovation or Overutilization?
Gurjit S. Kaeley¹, Dale Kraemer², Carmen Smotherman³ and Sunita Dodani⁴, ¹Rheumatology, University of Florida College of Medicine, Jacksonville, Jacksonville, FL, ²Center for Health Equity and Quality Research, Department of Neurology, University of Florida College of Medicine, Jacksonville, Jacksonville, FL, ³Center for Health Equity and Quality Research,, University of Florida College of Medicine, Jacksonville, Jacksonville, FL, ⁴Cardiology and Epidemiology, University of Florida College of Medicine, Jacksonville, Jacksonville, FL
Background/Purpose: MSK-US use has risen in the USA with recent disturbing findings suggesting greater utilization of interventional ultrasound by non-noradiologists compared to Radiologists. (1) This…
Abstract Number: 926 • 2015 ACR/ARHP Annual Meeting
Development of an Ultrasound Joint Inflammation Score for Rheumatoid Arthritis through a Data-Driven Approach
Anna-Birgitte Aga¹, Elisabeth Lie², Inge C Olsen², Hilde Berner Hammer³, Till Uhlig⁴, Désirée van der Heijde^5,6, Tore K. Kvien², Espen A. Haavardsholm² and the ARCTIC study group, ¹Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ³Postboks 23 Vinderen, Diakonhjemmet Hospital, Oslo, Norway, ⁴Diakonhjemmet Hospital, Oslo, Norway, ⁵Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Leiden, Netherlands, ⁶Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Background/Purpose: No consensus exists regarding which joints and tendons should be systematically assessed by ultrasonography (US) to assess inflammation in rheumatoid arthritis (RA). Validity and…
Abstract Number: 927 • 2015 ACR/ARHP Annual Meeting
Ultrasound Assessment of Heel Entheses in Spondyloarthritis Patients: A Comparative Study with Radiography and Magnetic Resonance Imaging
Rodrigo Aguila Maldonado¹, Santiago Ruta², Claudia Elizabeth Pena¹, Maria Laura Valuntas³, Gisela Pendón⁴, Dora Pereira⁴ and Mercedes Argentina García⁵, ¹Rheumatology Unit, HIGA San Martín La Plata, La Plata, Argentina, ²Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ³Servicio de Tomografía Computada y Resonancia Magnética, Sanatorio IPENSA, La Plata, Argentina, ⁴Hospital Ricardo Gutierrez, La Plata, La Plata, Argentina, ⁵Rheumatology Unit, HIGA San Martín, La Plata, Argentina
Background/Purpose: enthesitis is one of the main hallmarks of Spondyloarthritis (SpA), being heel entheses frequently involved. Different imaging modalities, such as conventional radiography (CR), ultrasound…
Abstract Number: 928 • 2015 ACR/ARHP Annual Meeting
The Value of Early Ultrasound-Detected Osteophytes in Hand Osteoarthritis: Predicting the Future
Alexander Mathiessen¹, Barbara Slatkowsky-Christensen², Tore K. Kvien³, Ida K. Haugen⁴ and Hilde Berner Hammer², ¹Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ³Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴P.O. Box 23, Diakonhjemmet Hospital, Vinderen, Norway
Background/Purpose: Ultrasound is more sensitive than conventional radiographs in detecting small osteophytes in hand osteoarthritis (OA). Osteophytes can be seen prior to joint space narrowing…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].